TRILLIUM THERAPEUTICS INC. Selling, General and Administrative Expense
TRILLIUM THERAPEUTICS INC. reported Selling, General and Administrative Expense of $5.44 million for the 12-month period ending 2019-12-31, per its 40-F filed 2020-03-10.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:SellingGeneralAndAdministrativeExpense · last filed 2020-03-10
CAD
| Period end | Selling General And Administrative Expense 12 month |
|---|---|
| 2018-12-31 | 3.58M CAD 20-F · filed 2019-03-11 |
| 2017-12-31 | 3.86M CAD 20-F · filed 2019-03-11 |
| 2016-12-31 | 3.93M CAD 40-F · filed 2018-04-04 |
USD
| Period end | Selling General And Administrative Expense 12 month |
|---|---|
| 2019-12-31 | $5.44M 40-F · filed 2020-03-10 |
| 2018-12-31 | $2.79M 40-F · filed 2020-03-10 |